All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Unequal Access to New Myasthenia Gravis Therapies Across Europe Highlights Healthcare Disparities

By

Euractiv

2h ago· 8 min readenInsight

Summary

This article examines the growing gap between medical innovation and patient access in the treatment of generalised myasthenia gravis (gMG) across Europe. While new therapies are transforming expectations for gMG care, unequal access persists across countries and communities. The piece highlights the need for better diagnosis, specialist referral pathways, and more consistent access to care to improve patient outcomes while supporting health system resilience, workforce participation, and economic sustainability.

Source

bskyUnequal Access to New Myasthenia Gravis Therapies Across Europe Highlights Healthcare Disparitieseuractiv.com

Key quotes

· 3 pulled
Generalised myasthenia gravis (gMG) may be a rare disease, but the questions it raises for Europe's healthcare systems are increasingly urgent: how quickly can medical innovation reach patients, and how can access be delivered evenly across countries and communities?
For people living with gMG the stakes are high.
While there is still no cure, advances in treatment are transforming expectations for
Snippet from the RSS feed
New therapies are changing what is possible in generalised myasthenia gravis care, yet unequal access across Europe continues to hold patients back. Better diagnosis, specialist referral and more consistent access to care could improve outcomes while supp

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.